Additional file 1 of Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions

Additional file 1: Table 1. Key inclusion criteria for the four pivotal mepolizumab studies. Figure 1. Rate of clinically significant exacerbations by OCS-dependence comorbidity category. Figure 2. Change from baseline in ACQ-5 score at Week 24 by OCS-dependence comorbidity category. Figure 3. Change from baseline in SGRQ total score at study end by OCS-dependence comorbidity category. Figure 4. Change from baseline in pre-bronchodilator FEV1 (mL) at Week 24 by OCS-dependence comorbidity category.